Hu Yan, Li Tongxin, Liu Wenguo, Zhu Damian, Feng Xin, Chen Yaokai, Zheng Huiwen
Tuberculosis Reference Laboratory, Chongqing Tuberculosis Control Institute, 400050, China.
Department of Clinical Laboratory, Chongqing Public Health Medical Center, Chongqing, 400036, China.
Heliyon. 2024 Jul 14;10(14):e34546. doi: 10.1016/j.heliyon.2024.e34546. eCollection 2024 Jul 30.
To investigate the prevalence of complex (MABC), drug resistance characteristics, and the relationship between clarithromycin (CLA) susceptibility and MABC genotype in Chongqing, China.
A total of 434 NTM patient isolates were collected between October 2018 and October 2019. Isolates confirmed to be non-tuberculous mycobacteria (NTM) were tested for minimal inhibitory concentrations of antimicrobial agents. In addition, and gene sequences were used to analyze the acquired macrolide resistance and inducible macrolide resistance.
Overall, 17 different NTM species were detected, of which (22.6 %, 91/403) was most prevalent. Amikacin, CLA, azithromycin and cefoxitin exhibited potent activities against MABC organisms, but no significant differences were observed in drug resistance rates between and ( > 0.05). On day 3 of culture, the acquired resistance rate against CLA was 7.4 % (9/121). Of 41 MABC isolates with inducible CLA resistant, 95.1 % (39/41) isolates belonged to the T28 sequevar, while the remaining 4.9 % (2/41) possessed the genotype. All C28 sequevar isolates were sensitive to CLA on day3 and day 14 of culture. Meanwhile, of the 5 T28 isolates with acquired resistance, all possessed 2058/2059 mutations, including 3 isolates with A2058C mutation and 2 isolates with A2059G mutation. While 2 of the 4 isolates with acquired resistance possessed the A2059G mutation, and one isolate possessed the A2058G mutation.
and gene could serve as useful markers for predicting macrolide susceptibility of MABC complex isolates.
调查中国重庆地区复合非结核分枝杆菌(MABC)的流行情况、耐药特征以及克拉霉素(CLA)敏感性与MABC基因型之间的关系。
2018年10月至2019年10月共收集434株非结核分枝杆菌(NTM)患者分离株。对确诊为非结核分枝杆菌的分离株进行抗菌药物最低抑菌浓度检测。此外,利用 和 基因序列分析获得性大环内酯耐药性和诱导性大环内酯耐药性。
总体上,检测到17种不同的NTM菌种,其中 (22.6%,91/403)最为常见。阿米卡星、CLA、阿奇霉素和头孢西丁对MABC菌株表现出较强的活性,但 和 之间的耐药率无显著差异( >0.05)。培养第3天,对CLA的获得性耐药率为7.4%(9/121)。在41株诱导性CLA耐药的MABC分离株中,95.1%(39/41)的分离株属于 T28序列型,其余4.9%(2/41)具有 基因型。所有 C28序列型分离株在培养第3天和第14天对CLA敏感。同时,在5株获得性耐药的 T28分离株中,均存在2058/2059突变,其中3株为A2058C突变,2株为A2059G突变。在4株获得性耐药分离株中,2株具有A2059G突变,1株具有A2058G突变。
和 基因可作为预测MABC复合分离株大环内酯敏感性的有用标志物。